For further details see:
Intellia CEO: Breakthrough gene-editing technology can be 'very, very successful' in certain diseasesFor further details see:
Intellia CEO: Breakthrough gene-editing technology can be 'very, very successful' in certain diseasesMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Beam Therapeutics Inc. Company Name:
BEAM Stock Symbol:
NASDAQ Market:
Beam Therapeutics Inc. Website:
CAMBRIDGE, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that its chief financial officer, Terry-Ann Burrell, will be leaving the company effective August 9, 2024...